Transaction expected to generate up to $35 million in upfront and milestone paymentsCelularity retains exclusive manufacturing rights, creating continued biomaterials revenue and margin ...

FLORHAM PARK, N.J., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a longevity-focused regenerative and cellular medicine company, today announced receipt of $12.2 ...

Inside each of your cells lies a nucleus, its master command center. Protected inside each nucleus are your chromosomes, ...

FLORHAM PARK, N.J., March 14, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ: CELU) (“Celularity” or the “Company”), a biotechnology company developing placental-derived allogeneic cell therapies ...

Regenerative medicine is advancing through rapid progress in stem cell science, gene editing, and engineered cellular systems. These tools now make it possible to direct cell fate, correct genetic ...

FLORHAM PARK, N.J., July 09, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company focused on addressing age-related and degenerative ...

Mechanical damage to the cell membrane was previously believed to trigger two simple cellular outcomes: recovery or death. However, a new study led by the Okinawa Institute of Science and Technology ...

The Forum on Regenerative Medicine hosted its first public workshop with the goal of developing a broad understanding of the opportunities and challenges associated with regenerative medicine cellular ...

This four-year degree is similar to BSc Cellular and Molecular Medicine but will give you the opportunity to gain valuable experience in cellular and molecular medicine in commercial or other research ...

Michael Rout has spent decades studying the molecular machinery that controls all traffic in and out of the cell’s nucleus. His research could lead to new treatments for cancer and viral diseases.